Trial Compares Ways To Elicit Patient Values About Prostate-Specific Antigen Screening
2/11/2013
Michael Patrick Pignone, M.D., M.P.H., of the University of North Carolina, Chapel Hill, and colleagues conducted a randomized clinical in October 2011 in which men underwent a values clarification task and then chose the most important attribute for prostate-specific antigen (PSA) screening...
Trial Compares Ways To Elicit Patient Values About Prostate-Specific Antigen Screening
2/11/2013
Michael Patrick Pignone, M.D., M.P.H., of the University of North Carolina, Chapel Hill, and colleagues conducted a randomized clinical in October 2011 in which men underwent a values clarification task and then chose the most important attribute for prostate-specific antigen (PSA) screening...
"Achilles' Heal" Found For Lymphoid Leukemia
2/11/2013
International Study Suggests Improved Treatment Alternative for Lymphoid Leukemia Discovering what they call the "Achilles' heel" for lymphoid leukemia, an international research team has tested a possible alternative treatment that eradicated the disease in mouse models. Reporting their results Feb...
Mouse Model Of Clear Cell Sarcoma Improves Understanding Of Rare, Deadly Cancer
2/11/2013
May Speed Development of Drugs to Target Gene Mutation Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises...
"Achilles' Heal" Found For Lymphoid Leukemia
2/11/2013
International Study Suggests Improved Treatment Alternative for Lymphoid Leukemia Discovering what they call the "Achilles' heel" for lymphoid leukemia, an international research team has tested a possible alternative treatment that eradicated the disease in mouse models. Reporting their results Feb...
VAXIMM Reports Positive Topline Data From First Oral Cancer Vaccine Trial
2/11/2013
Study meets endpoints and demonstrates safety and tolerability of VXM01 VAXIMM AG, a Swiss-German biotech company focusing on oral cancer vaccines, announced today topline data from the first clinical trial of its investigational oral cancer vaccine VXM01...
New Freezing Procedure Increases Availability Of Cord Blood Stem Cell Transplants For Patients
2/11/2013
A large enough number of stem cells are needed to ensure the success of a cord blood transplant. However, the quantity of stem cells isolated from umbilical cord blood is not always sufficient to meet that requirement. Researchers from the Etablissement Francais du Sang, Aquitaine-Limousin (France) have established a method to multiply cord blood stem cells to required quantity levels...
New Freezing Procedure Increases Availability Of Cord Blood Stem Cell Transplants For Patients
2/11/2013
A large enough number of stem cells are needed to ensure the success of a cord blood transplant. However, the quantity of stem cells isolated from umbilical cord blood is not always sufficient to meet that requirement. Researchers from the Etablissement Francais du Sang, Aquitaine-Limousin (France) have established a method to multiply cord blood stem cells to required quantity levels...
Treating Cancers, Neurological Disorders, And Infectious Diseases Using Unique Peptide
2/11/2013
UT Southwestern Medical Center scientists have synthesized a peptide that shows potential for pharmaceutical development into agents for treating infections, neurodegenerative disorders, and cancer through an ability to induce a cell-recycling process called autophagy...
Anticancer Drug Not Found To Accelerate Tumor Growth After Treatment Ends
2/11/2013
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans...